ResearcherGuiyang Medical UniversityActive in the last 2 years

Chao Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-6165-5450; OpenAlex author ID A5132606834. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

HOXC9 enhances cholesterol metabolism and malignancy in pancreatic ductal adenocarcinoma through ITGA10/FAK/PI3K/CREB-dependent HMGCR activation. Last author DOI 10.1007/s00535-026-02457-7 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dijie Zheng · 1 shared paper, 2026 · strength 0.30
- Paper HOXC9 enhances cholesterol metabolism and malignancy in pancreatic ductal adenocarcinoma through ITGA10/FAK/PI3K/CREB-d… DOI 10.1007/s00535-026-02457-7 ↗
Futang Li · 1 shared paper, 2026 · strength 0.30
- Paper HOXC9 enhances cholesterol metabolism and malignancy in pancreatic ductal adenocarcinoma through ITGA10/FAK/PI3K/CREB-d… DOI 10.1007/s00535-026-02457-7 ↗
Xinghao Sun · 1 shared paper, 2026 · strength 0.30
- Paper HOXC9 enhances cholesterol metabolism and malignancy in pancreatic ductal adenocarcinoma through ITGA10/FAK/PI3K/CREB-d… DOI 10.1007/s00535-026-02457-7 ↗
Liwen Chen · 1 shared paper, 2026 · strength 0.30
- Paper HOXC9 enhances cholesterol metabolism and malignancy in pancreatic ductal adenocarcinoma through ITGA10/FAK/PI3K/CREB-d… DOI 10.1007/s00535-026-02457-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.